SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Ajooni Biotech Ltd

BSE: 0 NSE: AJOONI ISIN: INE820Y01021
  |   Sector:  FMCG   |   Industry:  Animal Feed

Snapshot

Q.1 Which industry/sub-sector does Ajooni Biotech Ltd belong to?
Ajooni Biotech Ltd belongs to the FMCG sector, operating specifically within the Animal Feed segment.
Q.2 Is Ajooni Biotech Ltd a good quality company?
Ajooni Biotech Ltd is a quality company, based on a 10 year financial track record.
Q.3 Is Ajooni Biotech Ltd undervalued or overvalued?
Ajooni Biotech Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Ajooni Biotech Ltd a good buy now?
Ajooni Biotech Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Ajooni Biotech Ltd?
Ajooni Biotech Ltd revenue growth is 43.2% for FY-2025 , which is above its 5 year CAGR of 23.4% , indicating faster growth.
Q.2 Gross Profit margin of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Gross profit margin which is the profit after deduction of direct costs, is 4.7% for FY-2025 , which is above its 5 year median of 3.5% , indicating increasing margins.
Q.3 Operating Profit Margin of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 3.22% for FY-2025 , which is below its 5 year median of 3.23% indicating decreasing margins.
Q.4 Net Profit Margin of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Net Profit Margin is 2.94% for FY-2025 , is above with its 5 year median of 1.51%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 4.7 3.5
Operating Profit Margin 3.22 3.23
Net Profit Margin 2.94 1.51
Q.5 Return on Asset of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Return on Asset is 4.75%, which is above its 5 year historical median of 3.7%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Return on equity is 5.18% for FY-2025 , which is above its historical median of 5.12%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Return on capital employed is 6.94% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Cash conversion cycle is 101 days, above its historical median of 98 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 1.62 1.71
ROE 5.18 5.12
ROCE 6.94 6.94
Cash Conversion Cycle 101 days 98 days
Q.9 Debt to Equity ratio of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Debt-to-Equity ratio is 0.02 , which is lower with the industry average of 0.12 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Ajooni Biotech Ltd?
Ajooni Biotech Ltd Debt to cash flow from operations is -0.11 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Ajooni Biotech Ltd?
Promoters hold 26.89% of the Ajooni Biotech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Ajooni Biotech Ltd vs industry peers?
Ajooni Biotech Ltd revenue CAGR is 23.43% , compared to the industry median CAGR of 6.14% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 114.7 886.7
Gross Profit 5.4 33.7
Operating Profit 3.7 32
Net Profit 3.4 18
Operating Efficiency
Current Level Industry Median
Asset Turnover 1.62 1.76
ROE 5.18 12.91
ROCE 6.94 11.94
Cash Conversion Cycle (days) 100.66 31

Valuation & price assessment

Q.1 Stock return of Ajooni Biotech Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -33.43% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - -33.4% -4.3% -29.6%
Q.3 Valuation ratios of Ajooni Biotech Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 14.92 33.50 22.69
Price to Book 0.81 0.96 2.86
Price to Sales 0.48 0.49 1.13
EV to EBITDA 9.56 15.06 13.16

Check more companies

1. Avanti Feeds
2. Godrej Agrovet
3. Mukka Proteins
4. KSE
5. Ajooni Biotech
6. Prima Industries
7. Prima Agro
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×